Glen Coburn

Glen Coburn currently serves as the Director of Virology at Venatorx Pharmaceuticals, Inc., since February 2013, where expertise encompasses leading multidisciplinary project teams in antiviral product discovery and preclinical development. Previously, as the Director of Discovery Biology at Progenics Pharmaceuticals from December 2004 to October 2012, Glen provided scientific vision, managed project-specific functions, and contributed to budgets and timelines for discovery programs, while also serving as Principal Investigator on significant government grants. Prior experience includes a role as Sr. Scientist I at ViroPharma Incorporated, focusing on the optimization of small-molecule inhibitors for HCV. Glen holds a PhD in Biochemistry and Molecular Biology from The University of British Columbia and a BSc in Genetics from Western University.